See also this year's filing and all EDGAR filings for this company.
PDF Report 0001001316_2015_TG_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001001316, TG Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 85,215,029 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 799,391 |
| 2 | PropertyPlantAndEquipmentNet | 20,357 |
| 3 | remainder_Assets | 712,113 |
| 4 | LiabilitiesCurrent | 5,121,196 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,523,810 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,787,126 |
| 9 | ResearchAndDevelopmentExpense | 40,086,347 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 92,196 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 86,746,890 |
| 1 | Liabilities | 6,645,006 |
| 2 | Expenses | 55,873,473 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 80,101,884 |
| 5 | NetIncome | -55,781,277 |
| 6 | ComprehensiveNetIncome | -55,781,277 |
| 7 | BaseVar | 74,678,782 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.54 |
| 9 | EconomicCapitalRatio | 3.39 |